Search

everythinglearnresearchcommunity

for

Search:↓

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Men with testicular cancer were less likely to experience baldness and severe acne.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

The conclusion is that future hair loss treatments should target the root causes of hair thinning, not just promote hair growth.

The model suggests that scalp tension could lead to hair loss, with factors like blood vessel hardening, enlarged oil glands, and poor microcirculation also playing a role. It also hints at a possible link between skull shape and baldness pattern.

Parietal scalp area has lower hair density and smaller hair diameter in women with hair loss.

Acanthosis nigricans is a skin condition that may indicate a higher risk for insulin resistance and type 2 diabetes, and more research is needed to understand and treat it.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

Herbal compounds like ricinoleic acid, quercetin-3-O-rutinoside, and hinokiflavone may be safe and effective for treating hair loss.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Hormonal therapy is a good option for women with severe acne, especially when there's a chance of hormone imbalance.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Women with high androgen levels may have more severe COVID-19 symptoms.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Finasteride and dutasteride effectively treat hair loss in men and women, but may cause side effects like low libido and depression.

With careful management, people with congenital adrenal hyperplasia can have successful pregnancies and become parents.

Use 5% minoxidil or oral finasteride for mild-to-moderate hair loss, combine with hair transplant for severe cases.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Rats had lasting erectile problems after stopping a certain medication.

Finasteride may help some women with hair loss, but better options exist.

New treatments for hair loss show promise, especially finasteride for men and a stronger minoxidil formula.

A new hair loss treatment uses tiny needles to deliver a drug-loaded lipid carrier, promoting hair growth more effectively than current treatments.

Minoxidil dissolves better in propylene glycol + water than in supercritical CO2.